Abstract
Purpose
Optimal imaging modalities to select patients for endovascular thrombectomy (EVT) in the late window of acute ischemic stroke due to large vessel occlusions (AIS-LVO) are not known. We conducted a systematic review comparing outcomes of patients selected by non-contrast computed tomography (NCCT)/CT angiography (CTA) vs. those selected by CT perfusion (CTP) or magnetic resonance imaging (MRI) for EVT in these patients.
Methods
We searched PUBMED, EMBASE, and the Cochrane Library from January 1, 2000, to July 15, 2023, to identify studies comparing outcomes of patients selected for EVT by NCCT/CTA vs. CTP or MRI in the late time window for AIS-LVO. Primary outcome was independence (mRS 0–2) at 90 days or discharge. Secondary outcomes were symptomatic intracranial hemorrhage (sICH) and mortality. We pooled data across studies based on an inverse variance method.
Results
Six cohort studies with 4208 patients were included. Pooled results showed no significant difference in the rate of independence at 90 days or discharge (RR 0.96, 95% CI 0.88–1.03) and sICH (RR 1.26, 0.85–1.86) between patients selected by NCCT/CTA vs. CTP or MRI for EVT in the late window of AIS-LVO. However, patients selected by NCCT/CTA vs. CTP or MRI for EVT were associated with a higher risk of mortality (RR 1.21, 1.06–1.39).
Conclusion
For AIS-LVO in the late window, patients selected by NCCT/CTA compared with those selected by CTP or MRI for EVT might have a comparable rate of functional independence and sICH. Baseline NCCT/CTA may triage AIS-LVO in the late window.
Similar content being viewed by others
References
Nogueira RG, Jadhav AP, Haussen DC et al (2018) Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378:11–21. https://doi.org/10.1056/NEJMoa1706442
Albers GW, Marks MP, Christensen SKS et al (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378:708–718. https://doi.org/10.1056/NEJMoa1706442
Powers WJ, Rabinstein AA, Ackerson T et al (2018) American Heart Association Stroke, 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49:e46–e110. https://doi.org/10.1161/STR.0000000000000158
Turc G, Bhogal P, Fischer U et al (2019) European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischaemic stroke endorsed by Stroke Alliance for Europe (SAFE). Eur Stroke J 4:6–12. https://doi.org/10.1177/2396987319832140
Olthuis SGH, Pirson FAV, Pinckaers FME et al (2023) Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial. Lancet 401:1371–1380. https://doi.org/10.1016/S0140-6736(23)00575-5
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535
Fladt J, d’Esterre CD, Joundi R, McDougall C, Gensicke H, Barber P (2022) Acute stroke imaging selection for mechanical thrombectomy in the extended time window: is it time to go back to basics? A review of current evidence. J Neurol Neurosurg Psychiatry 93:238–245. https://doi.org/10.1136/jnnp-2021-328000
Sequeiros JM, Rodriguez-Calienes A, Chavez-Malpartida SS et al (2022) Stroke imaging modality for endovascular therapy in the extended window: systematic review and meta-analysis. J Neurointerv Surg 15:e46–e53. https://doi.org/10.1136/neurintsurg-2022-018896
Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D, Methods Work Group, Third US Preventive Services Task Force (2001) Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20:21–35. https://doi.org/10.1016/j.amepre.2020.01.001
Lin MH, Kamel H, Singer DE, Wu YL, Lee M, Ovbiagele B (2019) Perioperative/postoperative atrial fibrillation and risk of subsequent stroke and/or mortality. Stroke 50:1364–1371. https://doi.org/10.1161/STROKEAHA.118.023921
Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50:e344–e418. https://doi.org/10.1161/STR.0000000000000211
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2019) Cochrane handbook for systematic reviews of interventions, 2nd edn. John Wiley & Sons, Chichester, UK
Nguyen TN, Abdalkader M, Nagel S et al (2022) Noncontrast computed tomography vs computed tomography perfusion or magnetic resonance imaging selection in late presentation of stroke with large-vessel occlusion. JAMA Neurol 79:22–31. https://doi.org/10.1001/jamaneurol.2021.4082
Almekhlafi MA, Thornton J, Casetta I et al (2022) Stroke imaging prior to thrombectomy in the late window: results from a pooled multicentre analysis. J Neurol Neurosurg Psychiatry 93:468–474. https://doi.org/10.1136/jnnp-2021-327959
Dhillon PS, Butt W, Podlasek A et al (2022) Perfusion imaging for endovascular thrombectomy in acute ischemic stroke is associated with improved functional outcomes in the early and late time windows. Stroke 53:2770–2778. https://doi.org/10.1161/STROKEAHA.121.038010
Nogueira RG, Haussen DC, Liebeskind D et al (2021) Stroke imaging selection modality and endovascular therapy outcomes in the early and extended time windows. Stroke 52:491–497. https://doi.org/10.1161/STROKEAHA.120.031685
Cheng H, Yu Z, Ma G et al (2023) Does MRI add value in selecting patients for thrombectomy beyond the 6 h window? A matched-control analysis. Front Neurol 14:1135624. https://doi.org/10.3389/fneur.2023.1135624
Porto GBF, Chen CJ, Al Kasab S et al (2022) Association of noncontrast computed tomography and perfusion modalities with outcomes in patients undergoing late-window stroke thrombectomy. JAMA Netw Open 5:e2241291. https://doi.org/10.1001/jamanetworkopen.2022.41291
Demeestere J, Garcia-Esperon C, Garcia-Bermejo P et al (2017) Evaluation of hyperacute infarct volume using ASPECTS and brain CT perfusion core volume. Neurology 88:2248–2253. https://doi.org/10.1212/WNL.0000000000004028
Haussen DC, Dehkharghani S, Rangaraju S et al (2016) Automated CT perfusion ischemic core volume and noncontrast CT ASPECTS (Alberta Stroke Program Early CT Score): correlation and clinical outcome prediction in large vessel stroke. Stroke 47:2318–2322. https://doi.org/10.1161/STROKEAHA.116.014117
Sarraj A, Hassan AE, Grotta J et al (2020) Optimizing patient selection for endovascular treatment in acute ischemic stroke (SELECT): a prospective, multicenter cohort study of imaging selection. Ann Neurol 87:419–433. https://doi.org/10.1002/ana.25669
Desai SM, Tonetti DA, Molyneaux BJ (2020) Interaction between time, ASPECTS, and clinical mismatch. J Neurointerv Surg 12:911–914. https://doi.org/10.1136/neurintsurg-2020-015921
Nguyen TN, Klein P, Berberich A et al (2023) Late window imaging selection for endovascular therapy of large vessel occlusion stroke: an international survey. Stroke Vasc Interv Neurol 3:e000595. https://doi.org/10.1161/SVIN.122.000595
Goyal M, Jadhav AP, Bonafe A (2016) Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: results from the SWIFT PRIME randomized controlled trial. Radiology 279:888–897. https://doi.org/10.1148/radiol.2016160204
Yoshimura S, Sakai N, Yamagami H et al (2022) Endovascular therapy for acute stroke with a large ischemic region. N Engl J Med 386:1303–1313. https://doi.org/10.1056/NEJMoa2118191
Sarraj A, Hassan AE, Abraham MG et al (2023) Trial of endovascular thrombectomy for large ischemic strokes. N Engl J Med 388:1259–1271. https://doi.org/10.1056/NEJMoa2214403
Huo H, Ma G, Tong X et al (2023) Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med 388:1272–1283. https://doi.org/10.1056/NEJMoa2213379
Funding
This work was supported by Ministry of Science and Technology, Taiwan, grant numbers: MOST 108–2314-B-182–017-, MOST 109–2314-B-182–033-, and MOST 110–2314-B-182–036-MY2, and Chang Gung Memorial Hospital, Taiwan, grant numbers: CMRPG6H0191 and CMRPG6H0441.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Dr. Saver reported being an employee of the University of California, which has patent rights in retrieval devices for stroke. The University of California received payments on the basis of clinical trial contracts for the number of participants enrolled in multicenter clinical trials sponsored by Medtronic, Stryker, Cerenovus, BrainsGate, NONO Inc., and Boehringer Ingelheim (prevention only). The University of California receives grant support from the National Institutes of Health (NIH) for Dr. Saver’s service in leadership roles in the National Institute of Neurological Disorders and Stroke StrokeNet national clinical trial network and from Diffusion Pharma for Dr. Saver’s leadership role in the PHAST-TSC multicenter trial. Dr. Saver reported serving as an unpaid consultant to Genentech advising on the design and conduct of the PRISMS trial; neither the University of California nor Dr. Saver received any payments for this voluntary service. Dr. Saver paid for his own travel. Dr. Saver reported receiving contracted hourly payments and travel reimbursement for services as a scientific consultant advising on rigorous trial design and conduct to Medtronic, Stryker, Cerenovus, BrainsGate, Boehringer Ingelheim (prevention only), NONO Inc., BrainQ, and Abbott; contracted stock options for services as a scientific consultant advising on rigorous trial design and conduct to Rapid Medical; and personal fees from Johnson & Johnson and Novo Nordisk. Other authors have no disclosure or conflict of interest.
Ethics approval
This study was a meta-analysis of published papers and did not need IRB or ethic committee approval.
Informed consent
This study was a meta-analysis of published papers and did not enroll patients and therefore did not need informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lin, CH., Ovbiagele, B., Liebeskind, D.S. et al. Brain imaging prior to thrombectomy in the late window of large vessel occlusion ischemic stroke: a systematic review and meta-analysis. Neuroradiology 66, 809–816 (2024). https://doi.org/10.1007/s00234-024-03324-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-024-03324-z